Client News
Andera Partners co-leads a Series A extension round totalling € 47.75 million for radiopharmaceutical company Ariceum Therapeutics
InflaRx announces closing of the full exercise of greenshoe option increasing the proceeds of the recently announced public offering of ordinary shares to US$46 million
Abivax appoints Michael Ferguson as Chief Commercial Officer
Medigene AG: New data presented at AACR shows enhanced T cell functionality of MDG1015 in solid tumors
invIOs presents promising new clinical data in solid tumors from autologous cell therapy APN401 at AACR Annual Meeting 2023
Carbios accelerates its enzyme optimization with screening capabilities for millions of enzymes in a day
Abivax reports two-year efficacy and safety data of obefazimod phase 2b maintenance trial in ulcerative colitis
InflaRx announces closing of $40 million public offering of ordinary shares
Heidelberg Pharma AG: Interim management statement on the first three months of 2023
